Published since 1884 by the Society for the Study of Addiction
Editor-in-Chief, John Marsden
Home
About Us
Editorial Team
Aims and Scope
Performance Indicators
Ethical Policy
Top Papers
Resources for Authors
Newsroom
Contact Us
Menu
Www.addictionjournal.org
Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry
10 August, 2019